ASPM Is a Novel Marker for Vascular Invasion, Early Recurrence, and Poor Prognosis of Hepatocellular Carcinoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-07-5262
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

LAPTM4B Allele *2 Is a Marker of Poor Prognosis Following Hepatic Tumor Resection for Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2012English

Cadherin 17 Is Related to Recurrence and Poor Prognosis of Cytokeratin 19‑positive Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2017English

Genomic Analysis Reveals RhoC as a Potential Marker in Hepatocellular Carcinoma With Poor Prognosis

British Journal of Cancer
Cancer ResearchOncology
2004English

Galectin-3 Is Associated With a Poor Prognosis in Primary Hepatocellular Carcinoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

CELSR3 mRNA Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2019English

Overexpression of LAMC1 Predicts Poor Prognosis and Enhances Tumor Cell Invasion and Migration in Hepatocellular Carcinoma

Journal of Cancer
Oncology
2017English

Overexpression of RHEB Is Associated With Metastasis and Poor Prognosis in Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2018English

Peroxiredoxin 1, Restraining Cell Migration and Invasion, Is Involved in Hepatocellular Carcinoma Recurrence

Journal of Digestive Diseases
Gastroenterology
2018English

Neutrophils: Driving Progression and Poor Prognosis in Hepatocellular Carcinoma?

British Journal of Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy